Related Experiment Video

Updated: Aug 6, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through

Erdembileg Anuurad1, Jill Rubin, Guijing Lu

  • 1Department of Medicine, University of California, Davis, CA, USA.

Journal of Lipid Research
|August 5, 2006
PubMed

Insights

The apolipoprotein E (apoE) epsilon 2 allele shows a protective effect against coronary artery disease (CAD) in African Americans, linked to lower LDL cholesterol. This effect is not observed in Caucasians, as apoE2 does not impact their lipid profiles.

Area of Science:

  • Genetics and Cardiovascular Health
  • Human Population Studies
  • Biochemistry and Lipid Metabolism

Background:

  • Apolipoprotein E (apoE) is crucial for lipid metabolism.
  • Different apoE isoforms (epsilon 2, epsilon 3, epsilon 4) may influence cardiovascular disease risk.
  • Understanding these relationships across diverse populations is important.

Purpose of the Study:

  • To investigate the association between apoE isoforms and coronary artery disease (CAD) prevalence.
  • To examine potential differences in this association between African Americans and Caucasians.
  • To explore the role of lipid profiles in mediating the apoE-CAD relationship.

Main Methods:

  • Coronary angiography was performed on 224 African Americans and 326 Caucasians.
  • CAD was defined as >50% stenosis in at least one coronary artery.
  • ApoE allele frequencies and lipid levels (LDL cholesterol) were analyzed in relation to CAD presence.

Main Results:

  • In African Americans, apoE epsilon 2 allele carriers had significantly lower CAD prevalence (26%) compared to epsilon 3 (48%) and epsilon 4 (47%) carriers.
  • This protective effect of apoE2 in African Americans was associated with lower LDL cholesterol levels (106 mg/dl vs. 127-134 mg/dl).
  • No significant association between apoE isoforms and CAD was observed in Caucasians, nor did apoE2 significantly alter their lipid profiles.

Conclusions:

  • The apoE epsilon 2 allele appears to have a protective effect against CAD in African Americans, primarily mediated by a favorable impact on LDL cholesterol levels.
  • This protective association was not evident in Caucasians, suggesting population-specific effects of apoE isoforms on cardiovascular health.
  • The findings highlight the importance of considering genetic background and lipid metabolism when assessing cardiovascular risk associated with apoE genotypes.

More Related Videos

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...